Devyser Diagnostics AB (DVYSR) — Capital Reinvestment Ratio
Devyser Diagnostics AB (DVYSR) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (Skr12.10 Million) in capital expenditures (Skr300.00K). Check Devyser Diagnostics AB (DVYSR) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Devyser Diagnostics AB Capital Reinvestment Ratio (2018–2025)
This chart tracks Devyser Diagnostics AB's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Devyser Diagnostics AB cash conversion from operations.
Annual Capital Reinvestment Ratio for Devyser Diagnostics AB (2018–2025)
Year-by-year Capital Reinvestment Ratio for Devyser Diagnostics AB from 2018 to 2025. See Devyser Diagnostics AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | Skr8.20 Million | Skr1.50 Million | ▼ -96.6% |
| 2020 | 5.44x | Skr627.00K | Skr3.41 Million | ▲ +755.5% |
| 2019 | 0.64x | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr6.02 Million | Skr5.06 Million | — |